The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar
This study is currently recruiting participants.
Verified March 2012 by Simcere Pharmaceutical Co., Ltd
Sponsor:
Simcere Pharmaceutical Co., Ltd
Information provided by (Responsible Party):
Simcere Pharmaceutical Co., Ltd
ClinicalTrials.gov Identifier:
NCT01564329
First received: March 21, 2012
Last updated: March 23, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2013 |
| Estimated Primary Completion Date: | April 2013 (Final data collection date for primary outcome measure) |